Ferrellgas Partners LP (NYSE:FGP) shares moved down -0.20% in last trading session and ended the day at $20.15. FGP Gross Margin is 40.00% and its has a return on assets of 1.60%. Ferrellgas Partners LP (NYSE:FGP) quarterly performance is -0.38%.
Ferrellgas Partners LP (NYSE:FGP) was upgraded by Zacks from a “strong sell” rating to a “hold” rating in a research note issued on Friday, Market Beat.com reports.
Public Service Enterprise Group Inc. (NYSE:PEG) ended the last trading day at $38.66. Company weekly volatility is calculated as 2.41% and price to cash ratio as 32.76. Public Service Enterprise Group Inc. (NYSE:PEG) showed a weekly performance of -6.37%.
On 30 October, Public Service Enterprise Group Inc. (NYSE:PEG) announced a revised earnings outlook for the full year 2015. The company now expects earnings per share in a range of $2.85 to $2.95, while its previous guidance was in a range of $2.80 to $2.95 per share. Total operating earnings is expected in a range of $1.445 billion to $1500 billion last year.
On 06 November, Uranium Resources, Inc. (NASDAQ:URRE) shares moved down -0.37% and was closed at $0.76. URRE EPS growth in last 5 year was 24.40%. Uranium Resources, Inc. (NASDAQ:URRE) year to date (YTD) performance is -59.08%.
Uranium Resources, Inc. (NASDAQ:URRE) announced closure of the merger with Anatolia Energy Ltd. On November 10, 2015, the new URI shares exchanged for Anatolia shares will begin trading on Nasdaq under its existing trading symbol (as URRE) and on the ASX as CDIs under the new trading symbol “URI”.
Hecla Mining Co. (NYSE:HL) shares moved down -9.48% in last trading session and ended the day at $1.91. HL Gross Margin is 15.30% and its has a return on assets of 0.30%. Hecla Mining Co. (NYSE:HL) quarterly performance is -7.60%.
On 4 November, Hecla Mining Co. (NYSE:HL) announced third quarter net loss applicable to common shareholders of $10.0 million, or $0.03 per share, and a loss after adjustments applicable to common shareholders of $20.5 million, or $0.05 per share.
Orexigen Therapeutics, Inc. (NASDAQ:OREX) caters to the Healthcare space. It has a net profit margin of -43.80% and weekly performance is -11.84%. On the last day of trading company shares ended up at $2.68. Orexigen Therapeutics, Inc. (NASDAQ:OREX) distance from 50-day simple moving average (SMA50) is -2.78%.
On 5 November, Orexigen Therapeutics, Inc. (NASDAQ:OREX) announced business and financial results for the third quarter ended September 30, 2015. For the three months ended September 30, 2015, Orexigen reported a net loss of $11.1 million, or $0.09 per share, as compared to a profit of $11.3 million, or $0.09 per share, for the third quarter of 2014.